Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Adamis
Pharma
Product sales, mergers and layoffs may be in the cards at Adamis
With studies of its lone clinical asset on the rocks, Adamis is weighing its future. And as it stands, all options are on the table.
Fraiser Kansteiner
Oct 4, 2022 9:40am
Adamis recalls epinephrine after reports of glitches
Mar 23, 2022 12:28pm
Novartis bolsters Symjepi rollout amid EpiPen shortage
Jul 10, 2019 9:12am
Adamis sues rival epinephrine maker Kaléo for cybersquatting
Jul 2, 2019 10:58am
Novartis, Adamis keep swinging at EpiPen with new Symjepi dose
Sep 28, 2018 11:06am
